Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2015

View Archived Issues

Cyclic pyranopterin monophosphate substitution in neonates with molybdenum cofactor deficiency

Preclinical findings for NanoBio's intranasal nanoemulsion adjuvanted chlamydia vaccine

Morphotek and University of Wisconsin-Madison to study farletuzumab

Interim data released from phase II study of KRN-23 for XLH, phase III study enrolls first patient

Pluristem and Fukushima Medical University sign MOU for collaboration to study PLX-R18 for ARS

First patient recruited in phase II/III trial of Toca-511/Toca-FC in high-grade glioma

Coordinated delivery of anticancer drug combinations reduces toxicity

Texas Biomedical Research Institute receives NIH grant to develop cure for HIV infection in infants

Stem Cell Medicine, Ramot and Yeda sign license agreement for stem cell treatments

Intravenous Taigexyn achieves primary endpoint in phase III trial in community-acquired pneumonia

Fluorescent tracer MB-102 devised for noninvasive glomerular filtration rate measurement

Novavax initiates phase III trial of RSV F vaccine

Biotest cleared for phase III evaluation of BT-524 fibrinogen concentrate

Cytos Biotechnology and Kuros Biosurgery combine to create Kuros Biosciences

EMA validates Gilead's MAA for fixed-dose sofosbuvir/velpatasvir

New inhibitors block Ewing's sarcoma cell growth in vitro and in vivo

Radiation sensitizer NVX-108 receives FDA orphan drug designation

Calibr discloses integrin alphavbeta6 receptor antagonists

MUSC Foundation for Research Development patents anticancer agents

Molecular Targeting Technologies and NHRI develop anticancer drug conjugates

SpsB inhibitors reported in RQx Pharmaceuticals patent

Genentech and Roche report retinoid RORgamma ligands

Sealife Pharma presents antibacterial agents

Multiple dosing begun in phase I trial of CCX-872-B in pancreatic cancer

Samsung Bioepis obtains Korean approval for Renflexis and updates pipeline status

First-in-human data for ASTX-727 in myelodysplastic syndromes presented at ASH

Eli Lilly to cease development of basal insulin peglispro

Consortium invests in Athera Biotechnologies to further development of PC-mAB

First response to a BET inhibitor seen in NUT midline carcinoma

Zymeworks and GSK enter collaboration and license agreement for Fc-engineered antibodies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...